Navigate Up
  • Chat online
  • Write to us
  • 1800 22 1230
UTI - Pharma & Healthcare Fund Rating (source: Value Research)

NAV as on 16/05/2012 for

Rs. 31.250-0.14 (0.45%)
SMS: LNF to 5676756to get scheme details and NAV
  • Overview
  • Performance
  • Portfolio
  • Fund Manager
  • Scheme Documents
  • Fees
Investment Objective

Investment will be made in stocks of those companies engaged in the following areas:

  • An open-ended fund which exclusively invests in the equities of the Pharma & Healthcare sector companies. This fund is one of the growth sector funds aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and healthcare products and services.
Investment Information
Fund type
Open ended
Date of Inception
28/06/1999
Investment Plan
Income Retail
Fund size (Rs.Cr)
96.42 (as of 30th Apr 2012 )
Number of investors
23070 (as of 30th Apr 2012 )
Min. Investment
5000
Last Dividend
1.7
Bonus
N.A.
Fund Managers
Fund Manager

Mr. Lalit Nambiar

Lalit Nambiar is a Commerce Graduate and has done his Masters of Management Studies (MMS) and Chartered Financial Analyst (CFA).

Know More
Who Should Invest
  1. Suitable for a regular equity investor who has a higher risk appetite. Such a fund can be used to complement their core portfolio holdings. Suggested investment horizon is 2- 3 years
Performance (as of 31st Mar 2012)

Absolute Returns

Period Returns (%)
2009-2010 87.68
2010-2011 13.88
2011-2012 4.17
Since Inception 14.09
View detailed performance

Portfolio (as of 17th May 2012)

Sectoral Breakdown
(% as compared to Benchmark)

Market Capitalisation (%)

Large Mid Small
66.00 23.00 11.00

View complete asset allocation

Scenario 1:
Mr.Singh has invested Rs.1,00,000 in this fund since December 2000. See how his funds have performed over time.

Scenario 2:
Mr.Singh has invested Rs.1,00,000 in this fund since December 2000. See how his funds have performed over time.

Sectoral Breakdown (as of 30th Apr 2012)
Asset Allocation (as of 30th Apr 2012)

Market Capitalisation (%)

Large Mid Small
66.00 23.00 11.00
Detailed Portfolio (as of 30th Apr 2012)
Equity % to NAV
NCA 5.28
STRIDES ARCOLAB LTD. 2.17
AVENTIS PHARMA LTD 1.48
AUROBINDO PHARMA LTD. 1.36
NATCO PHARMA LTD. 1.09
UNICHEM LABORATORIES 1.00
INDOCO REMEDIES LTD. 0.73
SHASUN PHARMACEUTICALS LTD. 0.22
SUN PHARMA ADVANCED RESEARCH CO LTD. 2.21
RANBAXY LABORATORIES LTD. 0.71
LUPIN LTD. 9.99
BIOCON LTD. 3.23
DR. REDDY'S LABORATORIES LTD. 17.34
CIPLA LTD. 9.73
GLAXOSMITHKLINE PHARMACUETICALS LTD. 6.99
WYETH LTD. 5.61
PFIZER LIMITED 4.80
CADILA HEALTHCARE LTD. 4.73
DIVIS LABORATORIES LTD. 3.97
SUN PHARMACEUTICALS INDUSTRIES LTD. 17.36
Fund Manager - Biography
Fund Manager

Mr. Lalit Nambiar

Lalit Nambiar is a Commerce Graduate and has done his Masters of Management Studies (MMS) and Chartered Financial Analyst (CFA). He has been associated with UTI AMC Ltd. since December 2006. He is presently functioning as a Co-Fund Manager & Head of Research. He has an overall industry experience of 15 years having worked with good corporates like IIT Investrust Ltd., UTI Securities Exchange Ltd. and SBI Capital Markets Ltd.

Download Fund Documents
Load Structure
Entry Load Holding Period Exit Load
NIL < 1Year 1%
NIL <= 1Year NIL
Our 3 step
online application process
1
Register at invest@uti to buy funds online.
2
Fill up the online application form and make payments online.
3
Print and sign the form and send it with required documents at our nearest office or our executive will come and collect them
Already have this Fund?

Things you should know to make the best investment decision

Register with us
and recieve benefits:

  • Get tips on investment
  • Bust your myths
  • Get NAV alerts
  • Recieve emails on market outlook
....and much more!

Disclaimer:
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

DESIGNED BY : Indigo Consulting
DEVELOPED BY :  Prosares Solution Pvt Ltd